Mailhot Vega, Raymond B.Castellino, Sharon M.Pei, QinglinParsons, SusanRoberts, Kenneth B.Hodgson, DavidCharpentier, Anne-MarieFitzGerald, Thomas JKessel, Sandy K.Keller, Frank G.Kelly, KaraHoppe, Bradford S.2022-08-232022-08-232021-10-282022-05-05<p>Mailhot Vega RB, Castellino SM, Pei Q, Parsons S, Roberts KB, Hodgson D, Charpentier AM, Fitzgerald TJ, Kessel SK, Keller FG, Kelly K, Hoppe BS. Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma. Int J Part Ther. 2021 Oct 28;8(3):55-57. doi: 10.14338/IJPT-21-00012.1. PMID: 35127976; PMCID: PMC8768892. <a href="https://doi.org/10.14338/IJPT-21-00012.1">Link to article on publisher's site</a></p>2331-5180 (Linking)10.14338/IJPT-21-00012.135127976https://hdl.handle.net/20.500.14038/30725The indications for proton radiation therapy carry the strongest evidence in pediatric cancers. In a recently published letter, Bitterman et al reviewed factors associated with receipt of proton radiation therapy in patients enrolled in Children's Oncology Group (COG) solid tumor and CNS tumor trials. They demonstrated that Black children were less likely to receive this treatment than non-Hispanic white patients, a disparity that persisted when controlling for other demographic and clinical variables. We strongly commend them for their work, as addressing racism and infrastructural barriers to care requires its identification.en-US©Copyright 2021 The Author(s). This is an Open Access article distributed in accordance with Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/).http://creativecommons.org/licenses/by/3.0/particle therapyproton therapyradiation therapyhealth disparitiesHodgkin lymphomaHealth Services AdministrationHemic and Lymphatic DiseasesImmune System DiseasesNeoplasmsOncologyPediatricsRace and EthnicityRadiation MedicineEvaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin LymphomaEditorialhttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=3229&context=faculty_pubs&unstamped=1https://escholarship.umassmed.edu/faculty_pubs/219629018203faculty_pubs/2196